USD10
VKTX Ações
Conheça: Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
USD10
VKTX Ações
Conheça: Viking TherapeuticsViking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Estatísticas
JANELA DE NEGOCIAÇÃO
Aberta
FECHA ÀS
20:00 GMT+0
CAPITALIZAÇÃO DE MERCADO
US$ 3,73 bi
PREÇO DE ABERTURA
US$ 32,33
MÍNIMA (1 ano)
US$ 18,92
MÁXIMA (1 ano)
US$ 43,15
MÍNIMA (24 horas)
US$ 32,32
MÁXIMA (24 horas)
US$ 33,59
VOLUME (24 horas)
US$ 1,70 mi
51,88%
Histórico de preços
Time | Price | Change |
|---|---|---|
Hoje | US$ 32,33 | |
1 dia | US$ 32,70 | |
1 semana | US$ 36,00 | |
1 mês | US$ 34,42 | |
1 ano | US$ 29,28 |